Phase II study of personalized peptide vaccination for refractory bone and soft tissue sarcoma patients-Reference-Cited by-同舟云学术

Phase II study of personalized peptide vaccination for refractory bone and soft tissue sarcoma patients

Published:2013-08-06 Issue:10 Volume:104 Page:1285-1294
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Takahashi Ryuji¹,Ishibashi Yukinao²,Hiraoka Koji²,Matsueda Satoko³,Kawano Kouichirou⁴,Kawahara Akihiko⁵,Kage Masayoshi⁵,Ohshima Koichi⁵,Yamanaka Ryuya³,Shichijo Shigeki³,Shirouzu Kazuo¹,Itoh Kyogo³,Sasada Tetsuro³

Affiliation:

1. Department of SurgeryKurume University School of MedicineKurume Japan

2. Department of Orthopedics Kurume University School of Medicine Kurume Japan

3. Department of Immunology and Immunotherapy Kurume University School of Medicine Kurume Japan

4. Department of Gynecology Kurume University School of Medicine Kurume Japan

5. Department of Pathology Kurume University School of Medicine Kurume Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12226

Reference25 articles.

1. Soft tissue sarcoma as a model disease to examine cancer immunotherapy

2. Future directions for immunotherapeutic intervention against sarcomas

3. Phase II Study of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus in Patients With Advanced Bone and Soft Tissue Sarcomas

4. R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study

5. Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen ny-eso-1 but not mage-a1 or ct7

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Landscape of Immunotherapy for Advanced Sarcoma;Cancers;2023-04-13

2. Emerging Trends in Immunotherapy for Adult Sarcomas;The Oncologist;2023-03-11

3. Exploring the landscape of immunotherapy approaches in sarcomas;Frontiers in Oncology;2023-01-09

4. Potential association factors for developing effective peptide-based cancer vaccines;Frontiers in Immunology;2022-07-27

5. Immunotherapy in soft tissue sarcoma: current evidence and future perspectives in a variegated family of different tumor;Expert Review of Anticancer Therapy;2022-04-26